These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1633108)

  • 1. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent.
    Warner GL; Ludlow JW; Nelson DA; Gaur A; Scott DW
    Cell Growth Differ; 1992 Mar; 3(3):175-81. PubMed ID: 1633108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
    Joseph LF; Ezhevsky S; Scott DW
    Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
    Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta 1 inhibits DNA synthesis and phosphorylation of the retinoblastoma gene product in a rat liver epithelial cell line.
    Whitson RH; Itakura K
    J Cell Biochem; 1992 Mar; 48(3):305-15. PubMed ID: 1400615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.
    Yan Z; Hsu S; Winawer S; Friedman E
    Oncogene; 1992 Apr; 7(4):801-5. PubMed ID: 1565477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
    J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
    Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
    Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of transforming growth factor beta 1 regulatory activity in human non Hodgkin lymphomas.
    Kopper L; Ladanyi A; Mihalik R; Nagy P
    Anticancer Res; 1994; 14(1A):119-22. PubMed ID: 8166437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
    Snapper CM; Waegell W; Beernink H; Dasch JR
    J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
    Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
    J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Media acidification inhibits TGF beta-mediated growth suppression in cultured rabbit proximal tubule cells.
    Tovbin D; Franch HA; Alpern RJ; Preisig PA
    Proc Assoc Am Physicians; 1997 Nov; 109(6):572-9. PubMed ID: 9394419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
    Hasbold J; Klaus GG
    Eur J Immunol; 1990 Aug; 20(8):1685-90. PubMed ID: 2209683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
    Scott DW; O'Garra A; Warren D; Klaus GG
    J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
    Satterwhite DJ; White RL; Matsunami N; Neufeld KL
    Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.